Use of ingredients in infant formula for special medical purposes
Taiwan
Sep 30, 2022
The Taiwan Food and Drug Administration (TFDA) consulted on the amendment to the use restriction of 2′-fucosyllactose (2′-FL) produced by genetically modified Escherichia coli strain K-12 DH1 MDO MAP1001d (hereinafter referred to as “E. coli K-12 MAP1001d”) and genetically modified Escherichia coli strain BL21 (DE3) #1540 (hereinafter referred to as “E. coli BL21 (DE3) #1540”).
For further information (in Chinese), click on the Link
Enzymes approved as processing aids
Australia
Feb 20, 2023
Regulation of Baby Food Marketing in Thailand: A NetCode analysis
Thailand
Jul 06, 2022
Standard on complementary foods and nutritional supplements
China
Feb 28, 2022
Commission Implementing Decision on Decree on toddler drinks and toddler milk
Netherlands
Feb 07, 2022
Additional requirements on the use of claims on infant formula labeling
China
Nov 23, 2021
Amendments on Oat products and formulated supplements for children published by FSSAI
India
Nov 21, 2021
Decree on the advertising of food and beverages for children published by AESAN
Spain
Nov 12, 2021
European requirements on baby food adopted by Ukraine
Ukraine
Oct 28, 2021
Lists of bacterial cultures for foods and baby foods consulted by CFSA
China
Oct 27, 2021
